Abstract
Many plants contain ribosome inactivating proteins (RIPs) with N-glycosidase activity, which depurinate large ribosomal RNA and arrest protein synthesis. RIPs so far tested inhibit replication of mRNA as well as DNA viruses and these proteins, isolated from plants, are found to be effective against a broad range of viruses such as human immunodeficiency virus (HIV), hepatitis B virus (HBV) and herpes simplex virus (HSV). Most of the research work related to RIPs has been focused on antiviral activity against HIV; however, the exact mechanism of antiviral activity is still not clear. The mechanism of antiviral activity was thought to follow inactivation of the host cell ribosome, leading to inhibition of viral protein translation and host cell death. Enzymatic activity of RIPs is not limited to depurination of the large rRNA, in addition they can depurinate viral DNA as well as RNA. Recently, Phase I/II clinical trials have demonstrated the potential use of RIPs for treating patients with HIV disease. The aim of this review is to focus on various RIPs from plants associated with anti-HIV activity.
This is a preview of subscription content, access via your institution.
References
Barbieri L, Ferreras J M, Barraco A, et al. 1992. Some ribosome-inactivating proteins depurinate ribosomal RNA at multiple sites. Biochem J, 286: 1–4.
Bica I, McGovern B, Dhar R, et al. 2001. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dise, 132: 492–497.
Bourinbaiar A S, Huang S L. 1996. The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against Herpes Simplex Virus infection in vitro. Biochem Biophys Res Commun, 219: 923–929.
Byers V S, Levin A S, Waites L A, et al. 1990. A phase I/II study of trichosanthin treatment of HIV disease. AIDS, 4: 1189–1196.
D’cruz O J, Uckun F M. 2001. Pokeweed antiviral protein: a potential nonspermicidal prophylactic antiviral agent. Fertil Steril, 75: 106–114.
Fan J M, Zhang Q, Xu J, et al. 2009. Inhibition on hepatitis B virus in vitro of recombinant MAP30 from bitter melon. Mol Biol Rep, 36: 381–388.
He Y W, Guo C X, Pan Y F. 2008. Inhibition of hepatitis B virus replication by pokeweed antiviral protein. World J Gastroenterol, 14: 1592–1597.
Huang H, Chan H, Wang Y Y, et al. 2006. Trichosanthin suppress the elevation of p38 MAPK and Bcl-2 induced by HSV-1 infection in Vero cells. Life Sci, 13: 1287–1292.
Huang P L, Sun Y, Chen H C, et al. 1999. Proteolytic fragments of anti-HIV and anti-tumor proteins MAP30 an GAP31 are biologically active. Biochem Biophys Res Commun, 262: 615–623.
Kahn J O, Gorelick K J, Gatti G, et al. 1994. Safety, activity and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex. Antimicrob Agents Ch, 38: 260–267.
Kaur I, Yadav SK, Puri M, et al. 2011. Balsamin, a novel ribosome inactivating protein from the seeds of Balsam apple Momordica balsamina. Amino Acids (accepted).
Lee Huang S, Huang P L, Chen H C, et al. 1995a. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. Gene, 161: 151–156.
Lee Huang S, Huang P L, Huang P L, et al. 1995b. Inhibition of the integrase of human immunodeficiency (HIV) type I by anti-HIV plant proteins MAP30 and GAP31. Proc Natl Acad Sci USA, 92: 8818–8822.
Lee Huang S, Huang P L, Nara P L, et al. 1990. MAP30: a new inhibitor of HIV-1 infection and replication. FEBS Lett, 272: 12–18.
Mansouri S, Choudhary G, Sarzala P M. 2009. Suppression of human T-cell leukemia virus I gene expression by pokeweed antiviral protein. J Biol Chem, 284: 31453–31462.
McGrath M S, Hwang K M, Cladwell S E, et al. 1989. GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte linege. Proc Natl Acad Sci USA, 86: 2844–2848.
Narouz N, Allan P S, Wade A H, et al. 2003. Genital herpes serptestinh: a study of the epidemiology and patient knowledge and attitude among STD clinic attnders in conventry, UK. Sex Transum Infect, 79: 35–41.
Nugier F, Colin J N, Aymard M, et al. 1992. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey. J Med Virol, 36:1–12.
Peumans, W J, Hao Q, Van Damme E J M. 2001. Ribosome inactivating proteins from plants: more than RNA N-glycosidase? FASEB J, 15: 1493–1506.
Puri, M, Kaur I, Kanwar R K, et al. 2009 Ribosome inactivating protein (RIPs) from Momordica charantia for antiviral therapy. Curr Mol Med, 9: 1080–1094.
Puri, M. 2010. Biotechnological potential of Momordica balsamina revealed. Curr Pharma Biotechnol, 11, 229
Rajamohan F, Venkatachalam T K, Irvin J D, et al. 1999. Pokeweed antiviral protein isoforms PAP-I, PAP-II and PAP-III depurinate RNA of human immunodeficiency virus (HIV-1). Biochem Biophys Res Commun, 260: 453–458.
Sawasaki T, Morishita R, Ozawa A, et al. 1999. Mechanism of ribosome RNA apurinic site specific lyase. Nucleic Acids Symp Ser, 42: 257–258.
Stripe F, Battelli M G. 2006. Ribosome-inactivating proteins: progress and problems. Cell Mol Life Sci, 63: 1850–1866.
Stripe F. 2004. Ribosome-inactivating proteins. Toxins, 44: 371–383.
Taylor G P, Matsuoka M. 2005. Natural history of adult T-cell leukemia/lymphoma and approaches to therapy. Oncogne, 24: 6047–6057.
Uckun F M, Bellong K, O’ Neill K, et al. 1999. Toxicity, Biologcal activity and pharmacokinetic of TXU (Anti-CD)7-pokeweed antiviral protein in chimpanzees and adult patients infected with human immunodeficiency virus. J Pharmacol Exp Ther, 291: 1301–1307.
Uckun F M, Chelstrom L M, Ahlgren L T, et al. 1998. TXU (Anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus. Antimicrob Agents Ch, 47: 1052–1061.
Uckun F M, Rajamohan F, Pendergrass S, et al. 2003. Structure-based design and engineering of a non-toxic recombinant pokeweed antiviral protein with potent anti-human immunodeficiency virus activity. Antimicrob Agents Ch, 47: 1052–1061.
Wang J H, Nie H L, Tam S C, et al. 2002. Anti-HIV-1 property of trichosanthin correlates with its ribosome inactivating activity. FEBS Lett, 531: 295–298.
Zarling J M, Moran P A, Haffar O, et al. 1990. Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies. Nature, 347: 92–95.
Zhao W L, Feng D, Wu J, et al. 2010. Trichosanthin inhibits integration of human immunodeficiency virus type I trough depurinating the long-terminal repeats. Mol Biol Rep, 37:2093–2098.
Zhao W, Feng D, Sun S, et al. 2010. The aniviral protein of trichosanthin penetrates into human immunodeficiency virus type I. Acta Biochim Biophys Sin, 42: 91–97.
Author information
Authors and Affiliations
Corresponding author
Additional information
Foundation item: Indo-Swiss Joint research Program (ISJRP) #17/2011
Rights and permissions
About this article
Cite this article
Kaur, I., Gupta, R.C. & Puri, M. Ribosome inactivating proteins from plants inhibiting viruses. Virol. Sin. 26, 357–365 (2011). https://doi.org/10.1007/s12250-011-3223-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12250-011-3223-8
Key words
- Ribosome inactivating protein
- Human immunodeficiency virus
- Hepatitis B virus
- Herpes simplex virus